Biological Markers of Response to Treatment in Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Major Depressive Disorder
Interventions
DRUG

open-label selective serotonin reuptake inhibitor (SSRI)

Duration is 8 weeks. For escitalopram, starting dose is 10mg po qd,which can be increased up to 30mg po qd per clinical discretion. For citalopram, starting dose is 20mg po qd, which can be increased up to 60mg po qd per clinical discretion.

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00361218 - Biological Markers of Response to Treatment in Major Depressive Disorder | Biotech Hunter | Biotech Hunter